[1]
“MARKET ACCESS AND COMMERCIALISATION STRATEGIES FOR BIOSIMILARS IN COMPETITIVE AND CONSTRAINED HEALTHCARE SYSTEMS”, JournalNX, vol. 12, no. 10, pp. 12–31, Oct. 2026, doi: 10.26662/8qpc2724.